BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 35672530)

  • 1. Time interval between the diagnosis of breast cancer and brain metastases impacts prognosis after metastasis surgery.
    Michel A; Dinger TF; Santos AN; Pierscianek D; Darkwah Oppong M; Ahmadipour Y; Dammann P; Wrede KH; Hense J; Pöttgen C; Iannaccone A; Kimmig R; Sure U; Jabbarli R
    J Neurooncol; 2022 Aug; 159(1):53-63. PubMed ID: 35672530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Impact of Time Interval on Prognosis in Patients with Non-Small Cell Lung Cancer Brain Metastases After Metastases Surgery.
    Yang Z; Chen H; Jin T; Sun L; Li L; Zhang S; Wu B; Jin K; Zou Y; Sun C; Xia L
    World Neurosurg; 2023 Dec; 180():e171-e182. PubMed ID: 37704036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival outcomes of breast cancer patients with brain metastases: A multicenter retrospective study in Korea (KROG 16-12).
    Kim JS; Kim K; Jung W; Shin KH; Im SA; Kim HJ; Kim YB; Chang JS; Choi DH; Park YH; Kim DY; Kim TH; Choi BO; Lee SW; Kim S; Kwon J; Kang KM; Chung WK; Kim KS; Nam JH; Yoon WS; Kim JH; Cha J; Oh YK; Kim IA
    Breast; 2020 Feb; 49():41-47. PubMed ID: 31677532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognosis of breast cancer patients with brain metastasis treated with radiotherapy.
    Simonsen MK; Vrou Offersen B; Jensen AB
    Acta Oncol; 2023 Aug; 62(8):871-879. PubMed ID: 37498539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiographic markers of breast cancer brain metastases: relation to clinical characteristics and postoperative outcome.
    Michel A; Dinger T; Darkwah Oppong M; Rauschenbach L; Deuschl C; Ahmadipour Y; Pierscianek D; Wrede K; Hense J; Pöttgen C; Iannaccone A; Kimmig R; Sure U; Jabbarli R
    Acta Neurochir (Wien); 2022 Feb; 164(2):439-449. PubMed ID: 34677686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The clinicopathological evaluation of the breast cancer patients with brain metastases: predictors of survival.
    Tarhan MO; Demir L; Somali I; Yigit S; Erten C; Alacacioglu A; Ellidokuz H; Seseogullari O; Kucukzeybek Y; Can A; Dirican A; Bayoglu V; Akyol M
    Clin Exp Metastasis; 2013 Feb; 30(2):201-13. PubMed ID: 22915160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breast cancer patients with brain metastases or leptomeningeal disease: 10-year results of a national cohort with validation of prognostic indexes.
    Znidaric T; Gugic J; Marinko T; Gojkovic Horvat A; Paulin Kosir MS; Golo D; Ivanetic Pantar M; Ratosa I
    Breast J; 2019 Nov; 25(6):1117-1125. PubMed ID: 31286623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hormone receptors status: a strong determinant of the kinetics of brain metastases occurrence compared with HER2 status in breast cancer.
    Darlix A; Griguolo G; Thezenas S; Kantelhardt E; Thomssen C; Dieci MV; Miglietta F; Conte P; Braccini AL; Ferrero JM; Bailleux C; Jacot W; Guarneri V
    J Neurooncol; 2018 Jun; 138(2):369-382. PubMed ID: 29488184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical outcome of patients with brain metastases from breast cancer - A population based study over 21 years.
    Thulin A; Rönnerman E; Zhang C; De Lara S; Chamalidou C; Schoenfeldt A; Andersson C; Kovács A; Enlund F; Linderholm B
    Breast; 2020 Apr; 50():113-124. PubMed ID: 32145571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brain metastases from breast cancer.
    Santos J; Arantes J; Carneiro E; Ferreira D; Silva SM; Palma de Sousa S; Arantes M
    Clin Neurol Neurosurg; 2020 Oct; 197():106150. PubMed ID: 32920499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics and Prognostic Factors for Patients With HER2-overexpressing Breast Cancer and Brain Metastases in the Era of HER2-targeted Therapy: An Argument for Earlier Detection.
    Morikawa A; Wang R; Patil S; Diab A; Yang J; Hudis CA; McArthur HL; Beal K; Seidman AD
    Clin Breast Cancer; 2018 Oct; 18(5):353-361. PubMed ID: 29337140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk Factors of Brain Metastasis and Prognosis in HER2-Positive Breast Cancer: A Single-Institution Retrospective Analysis from China.
    Cai SL; Wang ZH; Chen XG; Han L; Gong GX; Chen YP; Lin XQ; Ma T; Chen HD
    Front Oncol; 2022; 12():905065. PubMed ID: 35832552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Pattern of Care for Brain Metastasis from Breast Cancer over the Past 10 Years in Korea: A Multicenter Retrospective Study (KROG 16-12).
    Kim JS; Kim K; Jung W; Shin KH; Im SA; Kim HJ; Kim YB; Chang JS; Kim JH; Choi DH; Park YH; Kim DY; Kim TH; Choi BO; Lee SW; Kim S; Kwon J; Kang KM; Chung WK; Kim KS; Nam JH; Yoon WS; Kim JH; Cha J; Oh YK; Kim IA
    Cancer Res Treat; 2022 Oct; 54(4):1121-1129. PubMed ID: 34990524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Outcomes and Prognostic Factors in HER-2 Positive Breast Cancer with Brain Metastasis: A Single-centre Experience.
    Karakaya S; Karadag I; Ates O; Cakmak Oksuzoglu OB; Demirci U
    J Coll Physicians Surg Pak; 2021 Feb; 31(2):166-170. PubMed ID: 33645183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of clinicopathological features and prognostic factors of breast cancer brain metastasis.
    Chen YR; Xu ZX; Jiang LX; Dong ZW; Yu PF; Zhang Z; Gu GL
    World J Clin Oncol; 2023 Nov; 14(11):445-458. PubMed ID: 38059189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breast cancer brain metastases - A 12 year review of treatment outcomes.
    De Ieso PB; Schick U; Rosenfelder N; Mohammed K; Ross GM
    Breast; 2015 Aug; 24(4):426-33. PubMed ID: 25881974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. External validation of Modified Breast Graded Prognostic Assessment for breast cancer patients with brain metastases: A multicentric European experience.
    Griguolo G; Jacot W; Kantelhardt E; Dieci MV; Bourgier C; Thomssen C; Bailleux C; Miglietta F; Braccini AL; Conte P; Ferrero JM; Guarneri V; Darlix A
    Breast; 2018 Feb; 37():36-41. PubMed ID: 29073498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain metastases after breast-conserving therapy and systemic therapy: incidence and characteristics by biologic subtype.
    Arvold ND; Oh KS; Niemierko A; Taghian AG; Lin NU; Abi-Raad RF; Sreedhara M; Harris JR; Alexander BM
    Breast Cancer Res Treat; 2012 Nov; 136(1):153-60. PubMed ID: 22968656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cystic brain metastasis is associated with poor prognosis in patients with advanced breast cancer.
    Sun B; Huang Z; Wu S; Ding L; Shen G; Cha L; Wang J; Song S
    Oncotarget; 2016 Nov; 7(45):74006-74014. PubMed ID: 27659537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term survival of breast cancer patients with brain metastases: subanalysis of the BMBC registry.
    Riecke K; Müller V; Neunhöffer T; Park-Simon TW; Weide R; Polasik A; Schmidt M; Puppe J; Mundhenke C; Lübbe K; Hesse T; Thill M; Wuerstlein R; Denkert C; Decker T; Fehm T; Nekljudova V; Rey J; Loibl S; Laakmann E; Witzel I
    ESMO Open; 2023 Jun; 8(3):101213. PubMed ID: 37075697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.